Crispr Therapeutics shares owned by Davy Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Davy Asset Management
from 13F filings
Historical chart of Davy Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Davy Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Davy Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18M | 283k | 64.81 |
| 2025-06-30 | $9.5M | 196k | 48.64 |
| 2025-03-31 | $2.2M | 65k | 34.03 |
| 2024-12-31 | $1.4M | 36k | 39.36 |
| 2024-09-30 | $640k | 14k | 46.98 |
| 2024-06-30 | $470k | 8.7k | 54.01 |